Prof. Julia Herzen
Prof. Dr. rer. nat.
Julia
Herzen
Technical University of Munich
Associate Professorship of Biomedical Imaging Physics (Prof. Herzen)
Postal address
James-Franck-Str. 1
85748 Garching b. München
Roles
Academic Program Director: Study Programs in Physics, Biomedical Engineering and Medical Physics, and Quantum Science and Technology
We develop novel X-ray imaging methods using highly brilliant synchrotron radiation and conventional laboratory X-ray sources. We mainly focus on quantitative multi-modal approaches combining spectral and phase-contrast imaging. Currently, we are aiming at applying these methods for improved breast cancer detection and for quantitative 3D virtual histology of human tissue.
Advanced Science
Abstract: Virtual histology using X-ray micro-computed tomography offers 3D tissue visualization, yet lacks the specificity of conventional histology, where targeted stains selectively highlight features like…
Optica
Abstract: X-ray microtomography at synchrotron sources is fundamentally limited by the high radiation dose applied to the samples, which restricts investigations to non-native tissue states and thereby…
IEEE Transactions on Image Processing
Abstract: Recent advances in propagation-based phase-contrast imaging, such as hierarchical imaging, have enabled the visualization of internal structures in large biological specimens and material samples.…
Scientific Reports
Abstract: Phase-contrast micro-tomography (CT) with synchrotron radiation can aid in the differentiation of subtle density variations in weakly absorbing soft tissue specimens. Modulation-based imaging (MBI)…
Frontiers in Immunology
Abstract: This study identifies and characterizes previously unrecognized medullary B cell niches within murine mucosa-draining lymph nodes (LNs), challenging the conventional understanding of LN architecture.…
Pharmaceutics
Abstract: Background/Objectives: Cardiovascular and pulmonary diseases are leading comorbidities n individuals with Down syndrome (DS). Although clinically well described, preclinical models fully…
Medical Physics
Abstract: Background: A significant proportion of false positive recalls of mammography-screened women is due to benign breast cysts and simple fibroadenomas. These lesions appear mammographically as…
Developments in X-Ray Tomography XV
Abstract: This study explores recent developments in quantitative phase-contrast microtomography using Talbot Array Illuminators (TAI) combined with Unified Modulated Pattern Analysis (UMPA). We first compare…
Developments in X-Ray Tomography XV
Abstract: Phase-contrast computed tomography enables the visualization of weakly-absorbing samples with high contrast. Speckle-based imaging (SBI) is a phase-sensitive X-ray imaging technique that requires the…
Developments in X-Ray Tomography XV
Abstract: In histology, the widely used staining agents are hematoxylin and eosin (H&E), with hematoxylin marking cell nuclei and eosin staining the cytoplasm. By this, the color-coded information enables the…
Winter term 2025/26
|
Title
|
Dates
|
Duration
|
Type
|
Lecturer (assistant)
|
|
|
|
1 |
OV
|
|
|
|
|
0.01 |
VO
|
|
|
|
|
4 |
PR
|
|
|
|
|
2 |
FO
|
|
|
|
|
2 |
VO
|
|
|
|
|
2 |
SE
|
|
|
|
|
1 |
UE
|
|
|
|
|
2 |
UE
|
|
|
|
|
2 |
UE
|
|
|
|
|
3 |
UE
|
|
|
|
|
0.1 |
KO
|
|
|
|
|
0.1 |
OV
|
|
|
|
|
2 |
VO
|
|
|
|
|
0.1 |
OV
|
|
|
|
|
2 |
VO
|
|
|
|
|
10 |
SE
|
|
|
|
|
10 |
FO
|
|
|
|
|
2 |
PS
|
|
|
|
|
2 |
VO
|
|
|
|
|
3 |
VI
|
|
|
|
|
2 |
RE
|
|
|
|
|
2 |
SE
|
|
Summer term 2026
|
Title
|
Dates
|
Duration
|
Type
|
Lecturer (assistant)
|
|
|
|
2 |
PS
|
|
|
|
|
1 |
OV
|
|
|
|
|
4 |
PR
|
|
|
|
|
2 |
FO
|
|
|
|
|
4 |
PR
|
|
|
|
|
4 |
PR
|
|
|
|
|
4 |
PR
|
|
|
|
|
2 |
VO
|
|
|
|
|
2 |
SE
|
|
|
|
|
1 |
UE
|
|
|
|
|
2 |
UE
|
|
|
|
|
0.1 |
KO
|
|
|
|
|
0.1 |
OV
|
|
|
|
|
2 |
VO
|
|
|
|
|
0.1 |
OV
|
|
|
|
|
2 |
VO
|
|
|
|
|
10 |
SE
|
|
|
|
|
10 |
SE
|
|
|
|
|
10 |
SE
|
|
|
|
|
10 |
SE
|
|
|
|
|
10 |
SE
|
|
|
|
|
10 |
FO
|
|
|
|
|
10 |
FO
|
|
|
|
|
10 |
FO
|
|
|
|
|
10 |
FO
|
|
|
|
|
10 |
FO
|
|
|
|
|
0.2 |
KO
|
|
|
|
|
2 |
PS
|
|
|
|
|
3 |
VI
|
|
|
|
|
2 |
RE
|
|
|
|
|
2 |
RE
|
|
|
|
|
2 |
SE
|
|
|
|
|
6 |
FO
|
|